STRAZZABOSCO MARIO

Ruolo: 
professore ordinario
Settore scientifico disciplinare: 
GASTROENTEROLOGIA (MED/12)
Telefono: 
0264488045
Stanza: 
U38, Piano: P05, Stanza: 5012
Via Pergolesi, 38 - 20900 MONZA

Pubblicazioni

  • Strazzabosco, M., Fiorotto, R., Cadamuro, M., Spirli, C., Mariotti, V., Kaffe, E., et al. (2018). Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium. BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE, 1864(4), 1374-1379. Dettaglio
  • Carbone, M., Cristoferi, L., Cortesi, P., Rota, M., Ciaccio, A., Okolicsanyi, S., et al. (2018). Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine. BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE, 1864(4 Part B), 1415-1422. Dettaglio
  • Kaffe, E., Fiorotto, R., Pellegrino, F., Mariotti, V., Amenduni, M., Cadamuro, M., et al. (2018). β-catenin and IL-1β dependent CXCL10 production drives progression of disease in a mouse model of Congenital Hepatic Fibrosis. HEPATOLOGY, 67(5), 1903-1919. Dettaglio
  • Cortesi, P., Belli, L., Facchetti, R., Mazzarelli, C., Perricone, G., De Nicola, S., et al. (2018). The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities. JOURNAL OF VIRAL HEPATITIS, 25(7), 791-801. Dettaglio
  • Ippolito, D., Querques, G., Okolicsanyi, S., Talei Franzesi, C., Pecorelli, A., Lombardi, S., et al. (2018). Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions. EUROPEAN JOURNAL OF RADIOLOGY, 106, 62-68. Dettaglio